Global Opioid Receptor Agonist Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
LPI (LP Information)' newest research report, the “Opioid Receptor Agonist Industry Forecast” looks at past sales and reviews total world Opioid Receptor Agonist sales in 2022, providing a comprehensive analysis by region and market sector of projected Opioid Receptor Agonist sales for 2023 through 2029. With Opioid Receptor Agonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Receptor Agonist industry.
This Insight Report provides a comprehensive analysis of the global Opioid Receptor Agonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Receptor Agonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Opioid Receptor Agonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Receptor Agonist and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Receptor Agonist.
The global Opioid Receptor Agonist market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Opioid Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Opioid Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Opioid Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Opioid Receptor Agonist players cover Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Receptor Agonist market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Opioid Receptor Agonist market?
What factors are driving Opioid Receptor Agonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Receptor Agonist market opportunities vary by end market size?
How does Opioid Receptor Agonist break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.
LPI (LP Information)' newest research report, the “Opioid Receptor Agonist Industry Forecast” looks at past sales and reviews total world Opioid Receptor Agonist sales in 2022, providing a comprehensive analysis by region and market sector of projected Opioid Receptor Agonist sales for 2023 through 2029. With Opioid Receptor Agonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Receptor Agonist industry.
This Insight Report provides a comprehensive analysis of the global Opioid Receptor Agonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Opioid Receptor Agonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Opioid Receptor Agonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Receptor Agonist and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Receptor Agonist.
The global Opioid Receptor Agonist market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Opioid Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Opioid Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Opioid Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Opioid Receptor Agonist players cover Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Fresenius Kabi, Mylan N.V., Allergan, US WorldMeds, Piramal Critical Care and DAIICHI SANKYO COMPANY, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Receptor Agonist market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Fentanyl
- Codeine
- Morphine
- Others
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva Pharmaceutical Industries
- Johnson & Johnson
- Pfizer
- Fresenius Kabi
- Mylan N.V.
- Allergan
- US WorldMeds
- Piramal Critical Care
- DAIICHI SANKYO COMPANY
- Purdue Pharma
- Hikma Pharmaceuticals
- Endo Pharmaceuticals
- Sun Pharmaceutical Industries
- Tris Pharma
- Indivior
What is the 10-year outlook for the global Opioid Receptor Agonist market?
What factors are driving Opioid Receptor Agonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Opioid Receptor Agonist market opportunities vary by end market size?
How does Opioid Receptor Agonist break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Receptor Agonist Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Opioid Receptor Agonist by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Opioid Receptor Agonist by Country/Region, 2018, 2022 & 2029
2.2 Opioid Receptor Agonist Segment by Type
2.2.1 Fentanyl
2.2.2 Codeine
2.2.3 Morphine
2.2.4 Others
2.3 Opioid Receptor Agonist Sales by Type
2.3.1 Global Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
2.3.2 Global Opioid Receptor Agonist Revenue and Market Share by Type (2018-2023)
2.3.3 Global Opioid Receptor Agonist Sale Price by Type (2018-2023)
2.4 Opioid Receptor Agonist Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.5 Opioid Receptor Agonist Sales by Application
2.5.1 Global Opioid Receptor Agonist Sale Market Share by Application (2018-2023)
2.5.2 Global Opioid Receptor Agonist Revenue and Market Share by Application (2018-2023)
2.5.3 Global Opioid Receptor Agonist Sale Price by Application (2018-2023)
3 GLOBAL OPIOID RECEPTOR AGONIST BY COMPANY
3.1 Global Opioid Receptor Agonist Breakdown Data by Company
3.1.1 Global Opioid Receptor Agonist Annual Sales by Company (2018-2023)
3.1.2 Global Opioid Receptor Agonist Sales Market Share by Company (2018-2023)
3.2 Global Opioid Receptor Agonist Annual Revenue by Company (2018-2023)
3.2.1 Global Opioid Receptor Agonist Revenue by Company (2018-2023)
3.2.2 Global Opioid Receptor Agonist Revenue Market Share by Company (2018-2023)
3.3 Global Opioid Receptor Agonist Sale Price by Company
3.4 Key Manufacturers Opioid Receptor Agonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Receptor Agonist Product Location Distribution
3.4.2 Players Opioid Receptor Agonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOID RECEPTOR AGONIST BY GEOGRAPHIC REGION
4.1 World Historic Opioid Receptor Agonist Market Size by Geographic Region (2018-2023)
4.1.1 Global Opioid Receptor Agonist Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Opioid Receptor Agonist Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Opioid Receptor Agonist Market Size by Country/Region (2018-2023)
4.2.1 Global Opioid Receptor Agonist Annual Sales by Country/Region (2018-2023)
4.2.2 Global Opioid Receptor Agonist Annual Revenue by Country/Region (2018-2023)
4.3 Americas Opioid Receptor Agonist Sales Growth
4.4 APAC Opioid Receptor Agonist Sales Growth
4.5 Europe Opioid Receptor Agonist Sales Growth
4.6 Middle East & Africa Opioid Receptor Agonist Sales Growth
5 AMERICAS
5.1 Americas Opioid Receptor Agonist Sales by Country
5.1.1 Americas Opioid Receptor Agonist Sales by Country (2018-2023)
5.1.2 Americas Opioid Receptor Agonist Revenue by Country (2018-2023)
5.2 Americas Opioid Receptor Agonist Sales by Type
5.3 Americas Opioid Receptor Agonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Receptor Agonist Sales by Region
6.1.1 APAC Opioid Receptor Agonist Sales by Region (2018-2023)
6.1.2 APAC Opioid Receptor Agonist Revenue by Region (2018-2023)
6.2 APAC Opioid Receptor Agonist Sales by Type
6.3 APAC Opioid Receptor Agonist Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Receptor Agonist by Country
7.1.1 Europe Opioid Receptor Agonist Sales by Country (2018-2023)
7.1.2 Europe Opioid Receptor Agonist Revenue by Country (2018-2023)
7.2 Europe Opioid Receptor Agonist Sales by Type
7.3 Europe Opioid Receptor Agonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Receptor Agonist by Country
8.1.1 Middle East & Africa Opioid Receptor Agonist Sales by Country (2018-2023)
8.1.2 Middle East & Africa Opioid Receptor Agonist Revenue by Country (2018-2023)
8.2 Middle East & Africa Opioid Receptor Agonist Sales by Type
8.3 Middle East & Africa Opioid Receptor Agonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Receptor Agonist
10.3 Manufacturing Process Analysis of Opioid Receptor Agonist
10.4 Industry Chain Structure of Opioid Receptor Agonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Receptor Agonist Distributors
11.3 Opioid Receptor Agonist Customer
12 WORLD FORECAST REVIEW FOR OPIOID RECEPTOR AGONIST BY GEOGRAPHIC REGION
12.1 Global Opioid Receptor Agonist Market Size Forecast by Region
12.1.1 Global Opioid Receptor Agonist Forecast by Region (2024-2029)
12.1.2 Global Opioid Receptor Agonist Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Receptor Agonist Forecast by Type
12.7 Global Opioid Receptor Agonist Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceutical Industries
13.1.1 Teva Pharmaceutical Industries Company Information
13.1.2 Teva Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
13.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceutical Industries Main Business Overview
13.1.5 Teva Pharmaceutical Industries Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Opioid Receptor Agonist Product Portfolios and Specifications
13.2.3 Johnson & Johnson Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Opioid Receptor Agonist Product Portfolios and Specifications
13.3.3 Pfizer Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Opioid Receptor Agonist Product Portfolios and Specifications
13.4.3 Fresenius Kabi Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Opioid Receptor Agonist Product Portfolios and Specifications
13.5.3 Mylan N.V. Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Opioid Receptor Agonist Product Portfolios and Specifications
13.6.3 Allergan Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 US WorldMeds
13.7.1 US WorldMeds Company Information
13.7.2 US WorldMeds Opioid Receptor Agonist Product Portfolios and Specifications
13.7.3 US WorldMeds Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 US WorldMeds Main Business Overview
13.7.5 US WorldMeds Latest Developments
13.8 Piramal Critical Care
13.8.1 Piramal Critical Care Company Information
13.8.2 Piramal Critical Care Opioid Receptor Agonist Product Portfolios and Specifications
13.8.3 Piramal Critical Care Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Piramal Critical Care Main Business Overview
13.8.5 Piramal Critical Care Latest Developments
13.9 DAIICHI SANKYO COMPANY
13.9.1 DAIICHI SANKYO COMPANY Company Information
13.9.2 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Portfolios and Specifications
13.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DAIICHI SANKYO COMPANY Main Business Overview
13.9.5 DAIICHI SANKYO COMPANY Latest Developments
13.10 Purdue Pharma
13.10.1 Purdue Pharma Company Information
13.10.2 Purdue Pharma Opioid Receptor Agonist Product Portfolios and Specifications
13.10.3 Purdue Pharma Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Purdue Pharma Main Business Overview
13.10.5 Purdue Pharma Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
13.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 Endo Pharmaceuticals
13.12.1 Endo Pharmaceuticals Company Information
13.12.2 Endo Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
13.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Endo Pharmaceuticals Main Business Overview
13.12.5 Endo Pharmaceuticals Latest Developments
13.13 Sun Pharmaceutical Industries
13.13.1 Sun Pharmaceutical Industries Company Information
13.13.2 Sun Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
13.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sun Pharmaceutical Industries Main Business Overview
13.13.5 Sun Pharmaceutical Industries Latest Developments
13.14 Tris Pharma
13.14.1 Tris Pharma Company Information
13.14.2 Tris Pharma Opioid Receptor Agonist Product Portfolios and Specifications
13.14.3 Tris Pharma Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Tris Pharma Main Business Overview
13.14.5 Tris Pharma Latest Developments
13.15 Indivior
13.15.1 Indivior Company Information
13.15.2 Indivior Opioid Receptor Agonist Product Portfolios and Specifications
13.15.3 Indivior Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Indivior Main Business Overview
13.15.5 Indivior Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Receptor Agonist Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Opioid Receptor Agonist by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Opioid Receptor Agonist by Country/Region, 2018, 2022 & 2029
2.2 Opioid Receptor Agonist Segment by Type
2.2.1 Fentanyl
2.2.2 Codeine
2.2.3 Morphine
2.2.4 Others
2.3 Opioid Receptor Agonist Sales by Type
2.3.1 Global Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
2.3.2 Global Opioid Receptor Agonist Revenue and Market Share by Type (2018-2023)
2.3.3 Global Opioid Receptor Agonist Sale Price by Type (2018-2023)
2.4 Opioid Receptor Agonist Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.5 Opioid Receptor Agonist Sales by Application
2.5.1 Global Opioid Receptor Agonist Sale Market Share by Application (2018-2023)
2.5.2 Global Opioid Receptor Agonist Revenue and Market Share by Application (2018-2023)
2.5.3 Global Opioid Receptor Agonist Sale Price by Application (2018-2023)
3 GLOBAL OPIOID RECEPTOR AGONIST BY COMPANY
3.1 Global Opioid Receptor Agonist Breakdown Data by Company
3.1.1 Global Opioid Receptor Agonist Annual Sales by Company (2018-2023)
3.1.2 Global Opioid Receptor Agonist Sales Market Share by Company (2018-2023)
3.2 Global Opioid Receptor Agonist Annual Revenue by Company (2018-2023)
3.2.1 Global Opioid Receptor Agonist Revenue by Company (2018-2023)
3.2.2 Global Opioid Receptor Agonist Revenue Market Share by Company (2018-2023)
3.3 Global Opioid Receptor Agonist Sale Price by Company
3.4 Key Manufacturers Opioid Receptor Agonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Receptor Agonist Product Location Distribution
3.4.2 Players Opioid Receptor Agonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOID RECEPTOR AGONIST BY GEOGRAPHIC REGION
4.1 World Historic Opioid Receptor Agonist Market Size by Geographic Region (2018-2023)
4.1.1 Global Opioid Receptor Agonist Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Opioid Receptor Agonist Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Opioid Receptor Agonist Market Size by Country/Region (2018-2023)
4.2.1 Global Opioid Receptor Agonist Annual Sales by Country/Region (2018-2023)
4.2.2 Global Opioid Receptor Agonist Annual Revenue by Country/Region (2018-2023)
4.3 Americas Opioid Receptor Agonist Sales Growth
4.4 APAC Opioid Receptor Agonist Sales Growth
4.5 Europe Opioid Receptor Agonist Sales Growth
4.6 Middle East & Africa Opioid Receptor Agonist Sales Growth
5 AMERICAS
5.1 Americas Opioid Receptor Agonist Sales by Country
5.1.1 Americas Opioid Receptor Agonist Sales by Country (2018-2023)
5.1.2 Americas Opioid Receptor Agonist Revenue by Country (2018-2023)
5.2 Americas Opioid Receptor Agonist Sales by Type
5.3 Americas Opioid Receptor Agonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Receptor Agonist Sales by Region
6.1.1 APAC Opioid Receptor Agonist Sales by Region (2018-2023)
6.1.2 APAC Opioid Receptor Agonist Revenue by Region (2018-2023)
6.2 APAC Opioid Receptor Agonist Sales by Type
6.3 APAC Opioid Receptor Agonist Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Receptor Agonist by Country
7.1.1 Europe Opioid Receptor Agonist Sales by Country (2018-2023)
7.1.2 Europe Opioid Receptor Agonist Revenue by Country (2018-2023)
7.2 Europe Opioid Receptor Agonist Sales by Type
7.3 Europe Opioid Receptor Agonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Receptor Agonist by Country
8.1.1 Middle East & Africa Opioid Receptor Agonist Sales by Country (2018-2023)
8.1.2 Middle East & Africa Opioid Receptor Agonist Revenue by Country (2018-2023)
8.2 Middle East & Africa Opioid Receptor Agonist Sales by Type
8.3 Middle East & Africa Opioid Receptor Agonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Receptor Agonist
10.3 Manufacturing Process Analysis of Opioid Receptor Agonist
10.4 Industry Chain Structure of Opioid Receptor Agonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Receptor Agonist Distributors
11.3 Opioid Receptor Agonist Customer
12 WORLD FORECAST REVIEW FOR OPIOID RECEPTOR AGONIST BY GEOGRAPHIC REGION
12.1 Global Opioid Receptor Agonist Market Size Forecast by Region
12.1.1 Global Opioid Receptor Agonist Forecast by Region (2024-2029)
12.1.2 Global Opioid Receptor Agonist Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Receptor Agonist Forecast by Type
12.7 Global Opioid Receptor Agonist Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Teva Pharmaceutical Industries
13.1.1 Teva Pharmaceutical Industries Company Information
13.1.2 Teva Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
13.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Teva Pharmaceutical Industries Main Business Overview
13.1.5 Teva Pharmaceutical Industries Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Opioid Receptor Agonist Product Portfolios and Specifications
13.2.3 Johnson & Johnson Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Opioid Receptor Agonist Product Portfolios and Specifications
13.3.3 Pfizer Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Opioid Receptor Agonist Product Portfolios and Specifications
13.4.3 Fresenius Kabi Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Opioid Receptor Agonist Product Portfolios and Specifications
13.5.3 Mylan N.V. Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Opioid Receptor Agonist Product Portfolios and Specifications
13.6.3 Allergan Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 US WorldMeds
13.7.1 US WorldMeds Company Information
13.7.2 US WorldMeds Opioid Receptor Agonist Product Portfolios and Specifications
13.7.3 US WorldMeds Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 US WorldMeds Main Business Overview
13.7.5 US WorldMeds Latest Developments
13.8 Piramal Critical Care
13.8.1 Piramal Critical Care Company Information
13.8.2 Piramal Critical Care Opioid Receptor Agonist Product Portfolios and Specifications
13.8.3 Piramal Critical Care Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Piramal Critical Care Main Business Overview
13.8.5 Piramal Critical Care Latest Developments
13.9 DAIICHI SANKYO COMPANY
13.9.1 DAIICHI SANKYO COMPANY Company Information
13.9.2 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Portfolios and Specifications
13.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 DAIICHI SANKYO COMPANY Main Business Overview
13.9.5 DAIICHI SANKYO COMPANY Latest Developments
13.10 Purdue Pharma
13.10.1 Purdue Pharma Company Information
13.10.2 Purdue Pharma Opioid Receptor Agonist Product Portfolios and Specifications
13.10.3 Purdue Pharma Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Purdue Pharma Main Business Overview
13.10.5 Purdue Pharma Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
13.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 Endo Pharmaceuticals
13.12.1 Endo Pharmaceuticals Company Information
13.12.2 Endo Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
13.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Endo Pharmaceuticals Main Business Overview
13.12.5 Endo Pharmaceuticals Latest Developments
13.13 Sun Pharmaceutical Industries
13.13.1 Sun Pharmaceutical Industries Company Information
13.13.2 Sun Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
13.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Sun Pharmaceutical Industries Main Business Overview
13.13.5 Sun Pharmaceutical Industries Latest Developments
13.14 Tris Pharma
13.14.1 Tris Pharma Company Information
13.14.2 Tris Pharma Opioid Receptor Agonist Product Portfolios and Specifications
13.14.3 Tris Pharma Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Tris Pharma Main Business Overview
13.14.5 Tris Pharma Latest Developments
13.15 Indivior
13.15.1 Indivior Company Information
13.15.2 Indivior Opioid Receptor Agonist Product Portfolios and Specifications
13.15.3 Indivior Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Indivior Main Business Overview
13.15.5 Indivior Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid Receptor Agonist Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Opioid Receptor Agonist Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Fentanyl
Table 4. Major Players of Codeine
Table 5. Major Players of Morphine
Table 6. Major Players of Others
Table 7. Global Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 8. Global Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Table 9. Global Opioid Receptor Agonist Revenue by Type (2018-2023) & ($ million)
Table 10. Global Opioid Receptor Agonist Revenue Market Share by Type (2018-2023)
Table 11. Global Opioid Receptor Agonist Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 13. Global Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Table 14. Global Opioid Receptor Agonist Revenue by Application (2018-2023)
Table 15. Global Opioid Receptor Agonist Revenue Market Share by Application (2018-2023)
Table 16. Global Opioid Receptor Agonist Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Opioid Receptor Agonist Sales by Company (2018-2023) & (K Units)
Table 18. Global Opioid Receptor Agonist Sales Market Share by Company (2018-2023)
Table 19. Global Opioid Receptor Agonist Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Opioid Receptor Agonist Revenue Market Share by Company (2018-2023)
Table 21. Global Opioid Receptor Agonist Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Opioid Receptor Agonist Producing Area Distribution and Sales Area
Table 23. Players Opioid Receptor Agonist Products Offered
Table 24. Opioid Receptor Agonist Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Opioid Receptor Agonist Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Opioid Receptor Agonist Sales Market Share Geographic Region (2018-2023)
Table 29. Global Opioid Receptor Agonist Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Opioid Receptor Agonist Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Opioid Receptor Agonist Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Opioid Receptor Agonist Sales Market Share by Country/Region (2018-2023)
Table 33. Global Opioid Receptor Agonist Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Opioid Receptor Agonist Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Opioid Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 36. Americas Opioid Receptor Agonist Sales Market Share by Country (2018-2023)
Table 37. Americas Opioid Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Opioid Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 39. Americas Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 40. Americas Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 41. APAC Opioid Receptor Agonist Sales by Region (2018-2023) & (K Units)
Table 42. APAC Opioid Receptor Agonist Sales Market Share by Region (2018-2023)
Table 43. APAC Opioid Receptor Agonist Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Opioid Receptor Agonist Revenue Market Share by Region (2018-2023)
Table 45. APAC Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 46. APAC Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 47. Europe Opioid Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 48. Europe Opioid Receptor Agonist Sales Market Share by Country (2018-2023)
Table 49. Europe Opioid Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Opioid Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 51. Europe Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 52. Europe Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Opioid Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Opioid Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Opioid Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Opioid Receptor Agonist
Table 60. Key Market Challenges & Risks of Opioid Receptor Agonist
Table 61. Key Industry Trends of Opioid Receptor Agonist
Table 62. Opioid Receptor Agonist Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Opioid Receptor Agonist Distributors List
Table 65. Opioid Receptor Agonist Customer List
Table 66. Global Opioid Receptor Agonist Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Opioid Receptor Agonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Opioid Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Opioid Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Opioid Receptor Agonist Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Opioid Receptor Agonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Opioid Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Opioid Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Opioid Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Opioid Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Opioid Receptor Agonist Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Opioid Receptor Agonist Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Opioid Receptor Agonist Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Opioid Receptor Agonist Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Teva Pharmaceutical Industries Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
Table 82. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Teva Pharmaceutical Industries Main Business
Table 84. Teva Pharmaceutical Industries Latest Developments
Table 85. Johnson & Johnson Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 86. Johnson & Johnson Opioid Receptor Agonist Product Portfolios and Specifications
Table 87. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Johnson & Johnson Main Business
Table 89. Johnson & Johnson Latest Developments
Table 90. Pfizer Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Opioid Receptor Agonist Product Portfolios and Specifications
Table 92. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Fresenius Kabi Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 96. Fresenius Kabi Opioid Receptor Agonist Product Portfolios and Specifications
Table 97. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Fresenius Kabi Main Business
Table 99. Fresenius Kabi Latest Developments
Table 100. Mylan N.V. Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 101. Mylan N.V. Opioid Receptor Agonist Product Portfolios and Specifications
Table 102. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Mylan N.V. Main Business
Table 104. Mylan N.V. Latest Developments
Table 105. Allergan Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 106. Allergan Opioid Receptor Agonist Product Portfolios and Specifications
Table 107. Allergan Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Allergan Main Business
Table 109. Allergan Latest Developments
Table 110. US WorldMeds Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 111. US WorldMeds Opioid Receptor Agonist Product Portfolios and Specifications
Table 112. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. US WorldMeds Main Business
Table 114. US WorldMeds Latest Developments
Table 115. Piramal Critical Care Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 116. Piramal Critical Care Opioid Receptor Agonist Product Portfolios and Specifications
Table 117. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Piramal Critical Care Main Business
Table 119. Piramal Critical Care Latest Developments
Table 120. DAIICHI SANKYO COMPANY Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 121. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Portfolios and Specifications
Table 122. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. DAIICHI SANKYO COMPANY Main Business
Table 124. DAIICHI SANKYO COMPANY Latest Developments
Table 125. Purdue Pharma Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 126. Purdue Pharma Opioid Receptor Agonist Product Portfolios and Specifications
Table 127. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Purdue Pharma Main Business
Table 129. Purdue Pharma Latest Developments
Table 130. Hikma Pharmaceuticals Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
Table 132. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Hikma Pharmaceuticals Main Business
Table 134. Hikma Pharmaceuticals Latest Developments
Table 135. Endo Pharmaceuticals Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 136. Endo Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
Table 137. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Endo Pharmaceuticals Main Business
Table 139. Endo Pharmaceuticals Latest Developments
Table 140. Sun Pharmaceutical Industries Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 141. Sun Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
Table 142. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Sun Pharmaceutical Industries Main Business
Table 144. Sun Pharmaceutical Industries Latest Developments
Table 145. Tris Pharma Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 146. Tris Pharma Opioid Receptor Agonist Product Portfolios and Specifications
Table 147. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Tris Pharma Main Business
Table 149. Tris Pharma Latest Developments
Table 150. Indivior Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 151. Indivior Opioid Receptor Agonist Product Portfolios and Specifications
Table 152. Indivior Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Indivior Main Business
Table 154. Indivior Latest Developments
Table 1. Opioid Receptor Agonist Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Opioid Receptor Agonist Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Fentanyl
Table 4. Major Players of Codeine
Table 5. Major Players of Morphine
Table 6. Major Players of Others
Table 7. Global Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 8. Global Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Table 9. Global Opioid Receptor Agonist Revenue by Type (2018-2023) & ($ million)
Table 10. Global Opioid Receptor Agonist Revenue Market Share by Type (2018-2023)
Table 11. Global Opioid Receptor Agonist Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 13. Global Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Table 14. Global Opioid Receptor Agonist Revenue by Application (2018-2023)
Table 15. Global Opioid Receptor Agonist Revenue Market Share by Application (2018-2023)
Table 16. Global Opioid Receptor Agonist Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Opioid Receptor Agonist Sales by Company (2018-2023) & (K Units)
Table 18. Global Opioid Receptor Agonist Sales Market Share by Company (2018-2023)
Table 19. Global Opioid Receptor Agonist Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Opioid Receptor Agonist Revenue Market Share by Company (2018-2023)
Table 21. Global Opioid Receptor Agonist Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Opioid Receptor Agonist Producing Area Distribution and Sales Area
Table 23. Players Opioid Receptor Agonist Products Offered
Table 24. Opioid Receptor Agonist Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Opioid Receptor Agonist Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Opioid Receptor Agonist Sales Market Share Geographic Region (2018-2023)
Table 29. Global Opioid Receptor Agonist Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Opioid Receptor Agonist Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Opioid Receptor Agonist Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Opioid Receptor Agonist Sales Market Share by Country/Region (2018-2023)
Table 33. Global Opioid Receptor Agonist Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Opioid Receptor Agonist Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Opioid Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 36. Americas Opioid Receptor Agonist Sales Market Share by Country (2018-2023)
Table 37. Americas Opioid Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Opioid Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 39. Americas Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 40. Americas Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 41. APAC Opioid Receptor Agonist Sales by Region (2018-2023) & (K Units)
Table 42. APAC Opioid Receptor Agonist Sales Market Share by Region (2018-2023)
Table 43. APAC Opioid Receptor Agonist Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Opioid Receptor Agonist Revenue Market Share by Region (2018-2023)
Table 45. APAC Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 46. APAC Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 47. Europe Opioid Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 48. Europe Opioid Receptor Agonist Sales Market Share by Country (2018-2023)
Table 49. Europe Opioid Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Opioid Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 51. Europe Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 52. Europe Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Opioid Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Opioid Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Opioid Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Opioid Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Opioid Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Opioid Receptor Agonist
Table 60. Key Market Challenges & Risks of Opioid Receptor Agonist
Table 61. Key Industry Trends of Opioid Receptor Agonist
Table 62. Opioid Receptor Agonist Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Opioid Receptor Agonist Distributors List
Table 65. Opioid Receptor Agonist Customer List
Table 66. Global Opioid Receptor Agonist Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Opioid Receptor Agonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Opioid Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Opioid Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Opioid Receptor Agonist Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Opioid Receptor Agonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Opioid Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Opioid Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Opioid Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Opioid Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Opioid Receptor Agonist Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Opioid Receptor Agonist Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Opioid Receptor Agonist Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Opioid Receptor Agonist Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Teva Pharmaceutical Industries Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
Table 82. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Teva Pharmaceutical Industries Main Business
Table 84. Teva Pharmaceutical Industries Latest Developments
Table 85. Johnson & Johnson Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 86. Johnson & Johnson Opioid Receptor Agonist Product Portfolios and Specifications
Table 87. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Johnson & Johnson Main Business
Table 89. Johnson & Johnson Latest Developments
Table 90. Pfizer Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Opioid Receptor Agonist Product Portfolios and Specifications
Table 92. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer Main Business
Table 94. Pfizer Latest Developments
Table 95. Fresenius Kabi Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 96. Fresenius Kabi Opioid Receptor Agonist Product Portfolios and Specifications
Table 97. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Fresenius Kabi Main Business
Table 99. Fresenius Kabi Latest Developments
Table 100. Mylan N.V. Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 101. Mylan N.V. Opioid Receptor Agonist Product Portfolios and Specifications
Table 102. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Mylan N.V. Main Business
Table 104. Mylan N.V. Latest Developments
Table 105. Allergan Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 106. Allergan Opioid Receptor Agonist Product Portfolios and Specifications
Table 107. Allergan Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Allergan Main Business
Table 109. Allergan Latest Developments
Table 110. US WorldMeds Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 111. US WorldMeds Opioid Receptor Agonist Product Portfolios and Specifications
Table 112. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. US WorldMeds Main Business
Table 114. US WorldMeds Latest Developments
Table 115. Piramal Critical Care Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 116. Piramal Critical Care Opioid Receptor Agonist Product Portfolios and Specifications
Table 117. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Piramal Critical Care Main Business
Table 119. Piramal Critical Care Latest Developments
Table 120. DAIICHI SANKYO COMPANY Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 121. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Portfolios and Specifications
Table 122. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. DAIICHI SANKYO COMPANY Main Business
Table 124. DAIICHI SANKYO COMPANY Latest Developments
Table 125. Purdue Pharma Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 126. Purdue Pharma Opioid Receptor Agonist Product Portfolios and Specifications
Table 127. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Purdue Pharma Main Business
Table 129. Purdue Pharma Latest Developments
Table 130. Hikma Pharmaceuticals Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
Table 132. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Hikma Pharmaceuticals Main Business
Table 134. Hikma Pharmaceuticals Latest Developments
Table 135. Endo Pharmaceuticals Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 136. Endo Pharmaceuticals Opioid Receptor Agonist Product Portfolios and Specifications
Table 137. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Endo Pharmaceuticals Main Business
Table 139. Endo Pharmaceuticals Latest Developments
Table 140. Sun Pharmaceutical Industries Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 141. Sun Pharmaceutical Industries Opioid Receptor Agonist Product Portfolios and Specifications
Table 142. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Sun Pharmaceutical Industries Main Business
Table 144. Sun Pharmaceutical Industries Latest Developments
Table 145. Tris Pharma Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 146. Tris Pharma Opioid Receptor Agonist Product Portfolios and Specifications
Table 147. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Tris Pharma Main Business
Table 149. Tris Pharma Latest Developments
Table 150. Indivior Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 151. Indivior Opioid Receptor Agonist Product Portfolios and Specifications
Table 152. Indivior Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Indivior Main Business
Table 154. Indivior Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioid Receptor Agonist
Figure 2. Opioid Receptor Agonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Receptor Agonist Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Opioid Receptor Agonist Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Opioid Receptor Agonist Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Fentanyl
Figure 10. Product Picture of Codeine
Figure 11. Product Picture of Morphine
Figure 12. Product Picture of Others
Figure 13. Global Opioid Receptor Agonist Sales Market Share by Type in 2022
Figure 14. Global Opioid Receptor Agonist Revenue Market Share by Type (2018-2023)
Figure 15. Opioid Receptor Agonist Consumed in Hospital Pharmacy
Figure 16. Global Opioid Receptor Agonist Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 17. Opioid Receptor Agonist Consumed in Online Pharmacy
Figure 18. Global Opioid Receptor Agonist Market: Online Pharmacy (2018-2023) & (K Units)
Figure 19. Opioid Receptor Agonist Consumed in Retail Pharmacy
Figure 20. Global Opioid Receptor Agonist Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 21. Global Opioid Receptor Agonist Sales Market Share by Application (2022)
Figure 22. Global Opioid Receptor Agonist Revenue Market Share by Application in 2022
Figure 23. Opioid Receptor Agonist Sales Market by Company in 2022 (K Units)
Figure 24. Global Opioid Receptor Agonist Sales Market Share by Company in 2022
Figure 25. Opioid Receptor Agonist Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Opioid Receptor Agonist Revenue Market Share by Company in 2022
Figure 27. Global Opioid Receptor Agonist Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Opioid Receptor Agonist Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 30. Americas Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 31. APAC Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 32. APAC Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 33. Europe Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 34. Europe Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 37. Americas Opioid Receptor Agonist Sales Market Share by Country in 2022
Figure 38. Americas Opioid Receptor Agonist Revenue Market Share by Country in 2022
Figure 39. Americas Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 40. Americas Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 41. United States Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Opioid Receptor Agonist Sales Market Share by Region in 2022
Figure 46. APAC Opioid Receptor Agonist Revenue Market Share by Regions in 2022
Figure 47. APAC Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 48. APAC Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 49. China Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Opioid Receptor Agonist Sales Market Share by Country in 2022
Figure 57. Europe Opioid Receptor Agonist Revenue Market Share by Country in 2022
Figure 58. Europe Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 59. Europe Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 60. Germany Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Opioid Receptor Agonist Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 69. Egypt Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Opioid Receptor Agonist in 2022
Figure 75. Manufacturing Process Analysis of Opioid Receptor Agonist
Figure 76. Industry Chain Structure of Opioid Receptor Agonist
Figure 77. Channels of Distribution
Figure 78. Global Opioid Receptor Agonist Sales Market Forecast by Region (2024-2029)
Figure 79. Global Opioid Receptor Agonist Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Opioid Receptor Agonist Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Opioid Receptor Agonist Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Opioid Receptor Agonist Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Opioid Receptor Agonist Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Opioid Receptor Agonist
Figure 2. Opioid Receptor Agonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Receptor Agonist Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Opioid Receptor Agonist Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Opioid Receptor Agonist Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Fentanyl
Figure 10. Product Picture of Codeine
Figure 11. Product Picture of Morphine
Figure 12. Product Picture of Others
Figure 13. Global Opioid Receptor Agonist Sales Market Share by Type in 2022
Figure 14. Global Opioid Receptor Agonist Revenue Market Share by Type (2018-2023)
Figure 15. Opioid Receptor Agonist Consumed in Hospital Pharmacy
Figure 16. Global Opioid Receptor Agonist Market: Hospital Pharmacy (2018-2023) & (K Units)
Figure 17. Opioid Receptor Agonist Consumed in Online Pharmacy
Figure 18. Global Opioid Receptor Agonist Market: Online Pharmacy (2018-2023) & (K Units)
Figure 19. Opioid Receptor Agonist Consumed in Retail Pharmacy
Figure 20. Global Opioid Receptor Agonist Market: Retail Pharmacy (2018-2023) & (K Units)
Figure 21. Global Opioid Receptor Agonist Sales Market Share by Application (2022)
Figure 22. Global Opioid Receptor Agonist Revenue Market Share by Application in 2022
Figure 23. Opioid Receptor Agonist Sales Market by Company in 2022 (K Units)
Figure 24. Global Opioid Receptor Agonist Sales Market Share by Company in 2022
Figure 25. Opioid Receptor Agonist Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Opioid Receptor Agonist Revenue Market Share by Company in 2022
Figure 27. Global Opioid Receptor Agonist Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Opioid Receptor Agonist Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 30. Americas Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 31. APAC Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 32. APAC Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 33. Europe Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 34. Europe Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Opioid Receptor Agonist Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Opioid Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 37. Americas Opioid Receptor Agonist Sales Market Share by Country in 2022
Figure 38. Americas Opioid Receptor Agonist Revenue Market Share by Country in 2022
Figure 39. Americas Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 40. Americas Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 41. United States Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Opioid Receptor Agonist Sales Market Share by Region in 2022
Figure 46. APAC Opioid Receptor Agonist Revenue Market Share by Regions in 2022
Figure 47. APAC Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 48. APAC Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 49. China Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Opioid Receptor Agonist Sales Market Share by Country in 2022
Figure 57. Europe Opioid Receptor Agonist Revenue Market Share by Country in 2022
Figure 58. Europe Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 59. Europe Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 60. Germany Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Opioid Receptor Agonist Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 69. Egypt Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Opioid Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Opioid Receptor Agonist in 2022
Figure 75. Manufacturing Process Analysis of Opioid Receptor Agonist
Figure 76. Industry Chain Structure of Opioid Receptor Agonist
Figure 77. Channels of Distribution
Figure 78. Global Opioid Receptor Agonist Sales Market Forecast by Region (2024-2029)
Figure 79. Global Opioid Receptor Agonist Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Opioid Receptor Agonist Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Opioid Receptor Agonist Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Opioid Receptor Agonist Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Opioid Receptor Agonist Revenue Market Share Forecast by Application (2024-2029)
